SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Takuya Konno, Owen A. Ross, Andreas Puschmann, Dennis W. Dickson, Zbigniew K. Wszolek, Autosomal dominant Parkinson's disease caused by SNCA duplications, Parkinsonism & Related Disorders, 2016, 22, S1

    CrossRef

  2. 2
    Alexandra I. Soto-Ortolaza, Owen A. Ross, Genetic susceptibility variants in parkinsonism, Parkinsonism & Related Disorders, 2016, 22, S7

    CrossRef

  3. 3
    Melinda Barkhuizen, David G. Anderson, Anne F. Grobler, Advances in GBA-associated Parkinson's disease – Pathology, presentation and therapies, Neurochemistry International, 2015,

    CrossRef

  4. 4
    Michaela E. Johnson, Larisa Bobrovskaya, An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene–environment interactions, NeuroToxicology, 2015, 46, 101

    CrossRef

  5. 5
    Aoife P. Kiely, Helen Ling, Yasmine T. Asi, Eleanna Kara, Christos Proukakis, Anthony H. Schapira, Huw R. Morris, Helen C. Roberts, Steven Lubbe, Patricia Limousin, Patrick A. Lewis, Andrew J. Lees, Niall Quinn, John Hardy, Seth Love, Tamas Revesz, Henry Houlden, Janice L. Holton, Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation, Molecular Neurodegeneration, 2015, 10, 1

    CrossRef

  6. 6
    Rosangela Ferese, Nicola Modugno, Rosa Campopiano, Marco Santilli, Stefania Zampatti, Emiliano Giardina, Annamaria Nardone, Diana Postorivo, Francesco Fornai, Giuseppe Novelli, Edoardo Romoli, Stefano Ruggieri, Stefano Gambardella, Four Copies ofSNCAResponsible for Autosomal Dominant Parkinson’s Disease in Two Italian Siblings, Parkinson's Disease, 2015, 2015, 1

    CrossRef

  7. 7
    J William Langston, Birgitt Schüle, Linda Rees, R Jeremy Nichols, Carrolee Barlow, Multisystem Lewy body disease and the other parkinsonian disorders, Nature Genetics, 2015, 47, 12, 1378

    CrossRef

  8. 8
    Wei Xu, Lan Tan, Jin-Tai Yu, The link between the SNCA gene and parkinsonism, Neurobiology of Aging, 2015, 36, 3, 1505

    CrossRef

  9. 9
    Andreas Puschmann, Zbigniew K. Wszolek, Movement Disorders, 2015,

    CrossRef

  10. 10
    Woojin Scott Kim, Katarina Kågedal, Glenda M Halliday, Alpha-synuclein biology in Lewy body diseases, Alzheimer's Research & Therapy, 2014, 6, 5-8

    CrossRef

  11. 11
    Hao Deng, Lamei Yuan, Genetic variants and animal models in SNCA and Parkinson disease, Ageing Research Reviews, 2014, 15, 161

    CrossRef

  12. 12
    Yasushi Shimo, Shihoko Natori, Genko Oyama, Madoka Nakajima, Hisato Ishii, Hajime Arai, Nobutaka Hattori, Subthalamic Deep Brain Stimulation for a Parkinson's Disease Patient With Duplication of SNCA, Neuromodulation: Technology at the Neural Interface, 2014, 17, 1
  13. 13
    M. Krenzer, C. Depboylu, J. Lu, W.H. Oertel, Tiermodelle der REM-Schlaf-Verhaltensstörung, Somnologie - Schlafforschung und Schlafmedizin, 2014, 18, 3, 155

    CrossRef

  14. 14
    Owen A. Ross, A Prognostic View on the Application of Individualized Genomics in Parkinson’s Disease, Current Genetic Medicine Reports, 2013, 1, 1, 52

    CrossRef

  15. 15
    Joanne Trinh, Matt Farrer, Advances in the genetics of Parkinson disease, Nature Reviews Neurology, 2013, 9, 8, 445

    CrossRef

  16. 16
    Antonio E. Elia, Simona Petrucci, Alfonso Fasano, Marco Guidi, Stefano Valbonesi, Laura Bernardini, Federica Consoli, Alessandro Ferraris, Alberto Albanese, Enza Maria Valente, Alpha-synuclein gene duplication: Marked intrafamilial variability in two novel pedigrees, Movement Disorders, 2013, 28, 6
  17. 17
    L. David Willison, Takashi Kudo, Dawn H. Loh, Dika Kuljis, Christopher S. Colwell, Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: Insights from a transgenic mouse model, Experimental Neurology, 2013, 243, 57

    CrossRef

  18. 18
    András Szamosi, Helga Nagy, Szabolcs Kéri, Delay Discounting of Reward and Caudate Nucleus Volume in Individuals with a-Synuclein Gene Duplication before and after the Development of Parkinson’s Disease, Neurodegenerative Diseases, 2013, 11, 2, 72

    CrossRef

  19. 19
    Suzanne Lesage, Mathieu Anheim, Franck Letournel, Luc Bousset, Aurélie Honoré, Nelly Rozas, Laura Pieri, Karine Madiona, Alexandra Dürr, Ronald Melki, Christophe Verny, Alexis Brice, G51D α-synuclein mutation causes a novel Parkinsonian–pyramidal syndrome, Annals of Neurology, 2013, 73, 4
  20. 20
    Andreas Puschmann, Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations, Parkinsonism & Related Disorders, 2013, 19, 4, 407

    CrossRef

  21. 21
    Dorota Hoffman-Zacharska, Dariusz Koziorowski, Owen A. Ross, Michał Milewski, Jarosław Poznański, Marta Jurek, Zbigniew K. Wszolek, Alexandra Soto-Ortolaza, Jarosław Sławek, Piotr Janik, Zygmunt Jamrozik, Anna Potulska-Chromik, Barbara Jasińska-Myga, Grzegorz Opala, Anna Krygowska-Wajs, Krzysztof Czyżewski, Dennis W. Dickson, Jerzy Bal, Andrzej Friedman, Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 11, 1057

    CrossRef

  22. 22
    Erika Guerrero, P. Vasudevaraju, Muralidhar L. Hegde, G. B. Britton, K. S. Rao, Recent Advances in α-Synuclein Functions, Advanced Glycation, and Toxicity: Implications for Parkinson’s Disease, Molecular Neurobiology, 2013, 47, 2, 525

    CrossRef

  23. 23
    Meike Kasten, Christine Klein, The many faces of alpha-synuclein mutations, Movement Disorders, 2013, 28, 6
  24. 24
    Nobutaka Hattori, Autosomal dominant Parkinsonism: its etiologies and differential diagnoses, Parkinsonism & Related Disorders, 2012, 18, S1

    CrossRef

  25. You have free access to this content25
    María-Jesús Sobrido, Pilar Cacheiro, Ángel Carracedo, Lars Bertram, Databases for neurogenetics: Introduction, overview, and challenges, Human Mutation, 2012, 33, 9
  26. 26
    Yoshio Tsuboi, Environmental-Genetic Interactions in the Pathogenesis of Parkinson's Disease, Experimental Neurobiology, 2012, 21, 3, 123

    CrossRef

  27. 27
    Han-Joon Kim, Beom S. Jeon, Min-Yung Yoon, Sung-Sup Park, Kwang-Woo Lee, Increased Expression of Alpha-Synuclein by SNCA Duplication is Associated with Resistance to Toxic Stimuli, Journal of Molecular Neuroscience, 2012, 47, 2, 249

    CrossRef

  28. 28
    M. Maral Mouradian, MicroRNAs in Parkinson's disease, Neurobiology of Disease, 2012, 46, 2, 279

    CrossRef

  29. 29
    Henry Houlden, Andrew B. Singleton, The genetics and neuropathology of Parkinson’s disease, Acta Neuropathologica, 2012, 124, 3, 325

    CrossRef

  30. 30
    Hui-Ming Gao, Jau-Shyong Hong, Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease, Progress in Neurobiology, 2011, 94, 1, 1

    CrossRef

  31. 31
    Karin Wirdefeldt, Margaret Gatz, Chandra A. Reynolds, Carol A. Prescott, Nancy L. Pedersen, Heritability of Parkinson disease in Swedish twins: a longitudinal study, Neurobiology of Aging, 2011, 32, 10, 1923.e1

    CrossRef

  32. 32
    David Crosiers, Jessie Theuns, Patrick Cras, Christine Van Broeckhoven, Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes, Journal of Chemical Neuroanatomy, 2011, 42, 2, 131

    CrossRef

  33. 33
    Michael J. Devine, Katrina Gwinn, Andrew Singleton, John Hardy, Parkinson's disease and α-synuclein expression, Movement Disorders, 2011, 26, 12
  34. 34
    Joshua M. Shulman, Philip L. De Jager, Mel B. Feany, Parkinson's Disease: Genetics and Pathogenesis, Annual Review of Pathology: Mechanisms of Disease, 2011, 6, 1, 193

    CrossRef

  35. 35
    S. Keri, A. A. Moustafa, C. E. Myers, G. Benedek, M. A. Gluck,  -Synuclein gene duplication impairs reward learning, Proceedings of the National Academy of Sciences, 2010, 107, 36, 15992

    CrossRef

  36. 36
    Takeshi Sekine, Hajime Kagaya, Manabu Funayama, Yuanzhe Li, Hiroyo Yoshino, Hiroyuki Tomiyama, Nobutaka Hattori, Clinical course of the first Asian family with Parkinsonism related to SNCA triplication, Movement Disorders, 2010, 25, 16
  37. 37
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  38. 38
    Lena Kertelge, Norbert Brüggemann, Alexander Schmidt, Vera Tadic, Claudia Wisse, Sylwia Dankert, Laura Drude, Joyce van der Vegt, Hartwig Siebner, Heike Pawlack, Peter P. Pramstaller, Maria Isabel Behrens, Alfredo Ramirez, Dirk Reichel, Carsten Buhmann, Johann Hagenah, Christine Klein, Katja Lohmann, Meike Kasten, Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease, Movement Disorders, 2010, 25, 15
  39. 39
    James F Morley, John E Duda, Olfaction as a biomarker in Parkinson’s disease, Biomarkers in Medicine, 2010, 4, 5, 661

    CrossRef

  40. 40
    Chae Won Shin, Hee Jin Kim, Sung Sup Park, Sung Yeun Kim, Ji Yeon Kim, Beom Seok Jeon, Two Parkinson's disease patients with α-synuclein gene duplication and rapid cognitive decline, Movement Disorders, 2010, 25, 7
  41. 41
    Marina Jendrach, Suzana Gispert, Filomena Ricciardi, Michael Klinkenberg, Rudolf Schemm, Georg Auburger, The mitochondrial kinase PINK1, stress response and Parkinson’s disease, Journal of Bioenergetics and Biomembranes, 2009, 41, 6, 481

    CrossRef

  42. 42
    Christopher S. Colwell, Circadian Dysfunction in Parkinson's Disease,
  43. 43
    Richard L. Doty, Christopher H. Hawkes, Kimberley P. Good, John E. Duda, Odor Perception and Neuropathology in Neurodegenerative Diseases and Schizophrenia,